Only medicines that have been properly authorised and prescribed through legitimate healthcare channels should be used
2 Enhanced glycaemic control is crucial for HF patients with T2D, who face increased cardiovascular risks
Who is a good candidate for ipamorelin
GLP-1RAs may be the drugs of choice for the treatment of diabetes because of their cardioprotective, neuroprotective and renal protective activities other than lowering blood glucose, while not causing side effects of hypoglycemia and weight gain, with a proven efficacy and safety (Sharma et al., 2018
How to Start TRT and Peptide Therapy Comprehensive Testing: Full lab panel to assess hormone levels, metabolic function, organ health, and overall wellness
In hereditary or acquired metabolic defects, an initial intravenous bolus of 50 mg/kg may be administered over two to three minutes, followed by maintenance doses of 50 mg/kg every six hours or continuous infusion to achieve a total daily exposure of up to 300 mg/kg in critical illness